These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7010372)

  • 1. Current developments with cholera vaccines: "Where do we go from here?".
    Finkelstein RA
    Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonization & protection in infant rabbits by a choleragenoid producing strain of Vibrio cholerae.
    Sinha VB; Srivastava BS
    Indian J Med Res; 1986 Aug; 84():139-41. PubMed ID: 3759164
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in cholera.
    Ghosh AK
    Indian J Pathol Bacteriol; 1974 Apr; 17(2):118-25. PubMed ID: 4455619
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].
    Carrada Bravo T
    Rev Alerg; 1993; 40(4):91-4. PubMed ID: 8143024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Developmental aspects of organism immunoreactivity in vaccination against cholera (author's transl)].
    Gorkova AV; Kuznĕcov OR; Naumsina MS; Adamov AK
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):136-42. PubMed ID: 126811
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholera.
    Rabbani GH
    Clin Gastroenterol; 1986 Jul; 15(3):507-28. PubMed ID: 3527493
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholera antibody response in immunized persons in a cholera free area. II. Vibriocidal antibodies.
    Chirescu N; Năcescu N; Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):149-53. PubMed ID: 4412422
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines.
    Jang H; Kim HS; Kim JA; Seo JH; Carbis R
    J Microbiol Biotechnol; 2009 Jan; 19(1):108-12. PubMed ID: 19190416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments with bacterial vaccines: cholera.
    Northrup RS
    Prog Immunobiol Stand; 1971; 5():328-9. PubMed ID: 4349833
    [No Abstract]   [Full Text] [Related]  

  • 18. [The current status of research on a cholera vaccine].
    Fournier JM
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-evaluation of antibacterial and antitoxin immunities in experimental cholera.
    Srivastava R; Sinha VB; Srivastava BS
    Indian J Med Res; 1979 Sep; 70():369-73. PubMed ID: 535945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genetic, molecular, and immunologic aspects of Vibrio cholerae infection].
    Fica AE; Cabello FC
    Rev Med Chil; 1993 Mar; 121(3):312-20. PubMed ID: 8248646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.